pre-IPO PHARMA

COMPANY OVERVIEW

Intezyne is developing a robust pipeline of product candidates offering the potential to target a range of disease areas.


LOCATION

  • Tampa, FL, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://intezyne.com/


    CAREER WEBSITE

    https://intezyne.com/careers/


    SOCIAL MEDIA


    INVESTORS

    gaston-capital-healthcare-fund


    PRESS RELEASES


    Jun 20, 2017

    Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer


    Mar 31, 2017

    Intezyne Technologies Initiates First-In-Human Trials for Topoisomerase-1 Inhibitor IT-141; GRP78 Inhibitor IT-139 to be Featured in AACR Symposium


    For More Press Releases


    Google Analytics Alternative